Physician profile
Brian Joseph
NPI 1205843836
$2,994.71
in general payments reported to CMS, 2019-2025
9 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $115 · 2021: $396 · 2022: $282 · 2023: $592 · 2024: $183 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $794.38 | 2019-2022 | |
| Mentor Worldwide LLC | $560.85 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Depuy Synthes Sales INC. | $478.63 | 2021-2023 | Trumatch |
| Galderma Laboratories, L.P. | $441.51 | 2019-2021 | |
| Sientra, INC. | $237.59 | 2019-2022 | |
| Abbvie INC. | $136.62 | 2023-2025 | |
| Avita Medical Americas, LLC | $132.13 | 2025 | Recell |
| Heron Therapeutics, INC. | $113.00 | 2023 | Zynrelef |
| Cumberland Pharmaceuticals, INC. | $100.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.